First, it is reported that seasonal influenza activity in the United States is increasing, with variations in activity by region.
Virologic surveillance shows that the majority of influenza viruses detected are Influenza A (H3N2).
Virus characterization data will be reported later this season.
Outpatient respiratory illness surveillance indicates that 2.7% of patient visits were due to respiratory illness, above the national baseline.
Moderate ILI activity was reported in 10 jurisdictions, and high or very high activity in 2 jurisdictions.
Long-term care facilities reported 0.5% of facilities with at least one influenza-positive test among residents.
Hospitalizations for influenza are starting to increase.
Mortality surveillance shows that 17.4% of deaths were attributed to pneumonia, influenza, or COVID-19, above the epidemic threshold.
No influenza-associated pediatric deaths have been reported during the current season.
Influenza activity is increasing, with the eastern and central parts of the country seeing higher levels of circulation.
It is emphasized that an annual flu vaccine is the best way to protect against influenza and its complications.
Flu vaccines and antiviral drugs are available for prevention and treatment.
The flu season is just getting started, and it is not too late to get vaccinated.
COVID-19 is also being closely monitored alongside influenza.
Methods for surveillance and additional information from state and international sources are provided for further reference.
